Breast Neoplasm Malignant Female: Clinical Trials

2 trials for Breast Neoplasm Malignant Female, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Breast Neoplasm Malignant Female: new trials by email Literature Review of Breast Neoplasm Malignant Female trials Research Report on Breast Neoplasm Malignant Female

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer
AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells - Advanced Breast Cancer, Breast Neoplasm Malignant Female
Phase 1 / Phase 2CompletedSun Yat-Sen Memorial Hospital of Sun Yat-Sen University152019-05-172023-04-13
Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)
Olaparib, Radiation therapy - Breast Neoplasms, Triple-Negative, Breast Neoplasm Malignant Female
Phase 1CompletedInstitut Curie242017-07-242025-11-24

Narrower conditions

Breast Neoplasms (1)  ·  Radiation Injuries (1)  ·  Triple Negative Breast Neoplasms (1)

Broader conditions

Breast Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Breast Neoplasms (1)  ·  Wounds and Injuries (1)

Interventions

Adenosine Diphosphate (1)  ·  Adenosine Diphosphate Ribose (1)  ·  Poly A (1)  ·  Radiotherapy (1)  ·  olaparib (1)

Sponsors

Institut Curie (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)

Countries

China (1)  ·  France (1)

Top investigators

Erwei Song, MD, PhD (1)

Results publications

PMID 32971187, PMID 36301572

NIH funding

2016 (1)